---
title: "Scotts Miracle - Gro | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.46 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284566171.md"
datetime: "2026-04-29T12:02:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284566171.md)
  - [en](https://longbridge.com/en/news/284566171.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284566171.md)
---

# Scotts Miracle - Gro | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.46 B

Revenue: As of FY2026 Q2, the actual value is USD 1.46 B, beating the estimate of USD 1.403 B.

EPS: As of FY2026 Q2, the actual value is USD 4.46, beating the estimate of USD 4.065.

#### Second Quarter Financial Highlights

Net sales for The Scotts Miracle-Gro Company increased by 5% to $1.46 billion compared to the prior year. The GAAP gross margin rate improved by 280 basis points, and the non-GAAP adjusted gross margin rate improved by 240 basis points over the prior year, reaching 41.8%. Non-GAAP adjusted EBITDA improved by 9 percent over the prior year, reaching $437.4 million. Net leverage for the company improved to 3.71x, down from 4.41x in the prior year, representing a 0.70x improvement.

#### Fiscal 2026 Outlook

The Scotts Miracle-Gro Company reaffirmed its fiscal 2026 guidance, projecting low single-digit growth in U.S. Consumer net sales and mid single-digit growth in non-GAAP adjusted EBITDA. The company expects a non-GAAP adjusted gross margin rate of at least 32% and non-GAAP adjusted net income per share from continuing operations ranging from $4.15 to $4.35. Additionally, free cash flow is anticipated to be $275 million, which is expected to reduce the leverage ratio to the high 3s.

### Related Stocks

- [SMG.US](https://longbridge.com/en/quote/SMG.US.md)

## Related News & Research

- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [China Natural Resources GAAP EPS of -$0.14](https://longbridge.com/en/news/286620443.md)
- [Range Impact GAAP EPS of -$0.02, revenue of $0.92M](https://longbridge.com/en/news/286725496.md)
- [Calidi Biotherapeutics GAAP EPS of -$0.43](https://longbridge.com/en/news/286474175.md)
- [Electro-Sensors GAAP EPS of -$0.03, revenue of $2.6M](https://longbridge.com/en/news/286518577.md)